Related Experiment Video
Updated: Feb 3, 2026

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice
Published on: March 1, 2017
Adipokines in Multiple Sclerosis Patients with and without Optic Neuritis as the First Clinical Presentation
Berna Düzel1, Yusuf Tamam1, Arzu Çoban2
1a Department of Neurology, Faculty of Medicine , Dicle University , Diyarbakır , Turkey.
Background:
Adipocytokines have been implied to be involved in multiple sclerosis (MS) pathogenesis. MS patients whose first clinical episode is optic neuritis (ON) have been reported to display a milder disease course. In this study, we aimed to show whether this milder disease course is related to reduced adipokine production.
Methods:
A total of 55 (24 with ON as the first clinical episode) relapsing-remitting MS (RRMS) patients and 40 healthy individuals were recruited. Concentrations of adipokines were measured in sera by ELISA.
Results:
The levels of adiponectin, leptin, resistin, monocyte chemoattractant protein-1 (MCP-1) and IL-8 were significantly higher in RRMS patients compared with healthy controls. RRMS cases starting with ON had lower expanded disability status scale scores. Serum adiponectin, leptin, resistin and MCP-1 levels were significantly lower in MS patients, whose first clinical episode was ON.
Conclusions:
MS patients with ON as the first manifestation display both lower disability scores and reduced serum adipokine levels implying that adipocytokine production is associated with MS progression. Exact mechanisms of this association in MS patients with first episode ON need to be further studied.
Insights
Multiple sclerosis (MS) patients with optic neuritis (ON) as the initial symptom exhibit milder disease and lower adipokine levels. This suggests adipocytokine production is linked to MS progression, warranting further investigation into the underlying mechanisms.
Area of Science:
- Immunology
- Neurology
- Endocrinology
Background:
- Adipocytokines are implicated in multiple sclerosis (MS) pathogenesis.
- MS patients experiencing optic neuritis (ON) first often show a milder disease course.
- This study investigates the link between reduced adipokine production and milder MS progression.
Purpose of the Study:
- To determine if a milder MS disease course, particularly in patients with ON as the first clinical episode, is associated with reduced adipokine production.
- To compare adipokine levels in relapsing-remitting MS (RRMS) patients and healthy controls.
- To explore the relationship between specific adipokines and disease severity in MS.
Main Methods:
- Serum samples were collected from 55 RRMS patients (24 with initial ON) and 40 healthy controls.
- Adipokine concentrations (adiponectin, leptin, resistin, MCP-1, IL-8) were quantified using ELISA.
- Expanded Disability Status Scale (EDSS) scores were assessed in MS patients.
Main Results:
- RRMS patients exhibited significantly higher levels of adiponectin, leptin, resistin, MCP-1, and IL-8 compared to healthy controls.
- MS patients whose first episode was ON had lower EDSS scores.
- Serum levels of adiponectin, leptin, resistin, and MCP-1 were significantly lower in MS patients with initial ON.
Conclusions:
- MS patients presenting initially with ON demonstrate both reduced disability and lower serum adipokine levels.
- These findings imply a significant association between adipocytokine production and MS progression.
- Further research is needed to elucidate the precise mechanisms linking adipocytokines to MS in patients with initial ON.
Related Concept Videos
Self-Presentation
Self-Presentation: Self-Monitoring and Self-Handicapping
Strategies of Self-Presentation I: Strategic Self-Presentation
Processes of Self-Presentation
Strategies of Self-Presentation II: Self-Verification
Strategies of Self-Presentation III: Self-Monitoring

